Apogee Therapeutics, Inc.
APGEDelisted Sep 3, 2026- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001974640
Apogee Therapeutics, Inc. was delisted on Sep 3, 2026; its insiders filed their last Form 4 on Sep 3, 2026; 289 institutions reported holding it in 13F filings for Q2 2026, worth $8.93B in total; Soros Fund Management was the only superinvestor holding it.
Holders of 5% or more of APGE
Holders whose latest Schedule 13D or 13G filing reports 5% or more of Apogee Therapeutics, Inc., largest stake first. The change is against the holder's previous filing.
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 5.50%2.52M shares | – | Oct 22, 20243 filings | Jul 16, 2025 | SEC |
Stakes are as of each holder's latest filing. Holders whose last filing was in the old format (before December 18, 2024) have no stake on record and are not listed, and after an acquisition or delisting holders usually stop filing.
13D and 13G filings
40 Schedule 13D and 13G filings on Apogee Therapeutics, Inc., newest first, including old-format filings without a stake.
| Filed (ET) | Filer | Form | Stake | Change | Event date | Filing |
|---|---|---|---|---|---|---|
| Sep 8, 20265:08 PM ET | Venrock Healthcare Capital Partners III, L.P.and 6 others | 13D/A | 0.00%0 shares | –Below 5% | Sep 3, 2026 | SEC |
| Sep 3, 20265:31 PM ET | Fairmount Funds Management LLCand 3 others | 13D/A | 0.00%0 shares | −9.99 ppfrom 9.99%Below 5% | Sep 3, 2026 | SEC |
| Jul 8, 202612:59 PM ET | Wellington Management Group LLPand 2 others | 13G/A | 0.90%564.3K shares | −7.80 ppfrom 8.70%Below 5% | Jun 30, 2026 | SEC |
| Jul 8, 202611:30 AM ET | T. Rowe Price Investment Management, Inc. | 13G/A | 1.30%773.0K shares | −15.50 ppfrom 16.80%Below 5% | Jun 30, 2026 | SEC |
| Jul 8, 202610:11 AM ET | FMR LLCand 1 other | 13G/A | 4.00%2.49M shares | −11.00 ppfrom 15.00%Below 5% | Jun 30, 2026 | SEC |
| Jun 23, 20265:00 PM ET | Fairmount Funds Management LLCand 3 others | 13D/A | 9.99%6.81M shares | 0.00 ppfrom 9.99% | Jun 18, 2026 | SEC |
| Apr 8, 20263:26 PM ET | T. Rowe Price Investment Management, Inc. | 13G/A | 16.80%10.3M shares | +5.50 ppfrom 11.30% | Mar 31, 2026 | SEC |
| Mar 27, 20265:30 PM ET | Fairmount Funds Management LLCand 3 others | 13D/A | 9.99%6.76M shares | 0.00 ppfrom 9.99% | Mar 26, 2026 | SEC |
| Mar 26, 20263:42 PM ET | Vanguard Group Inc | 13G/A | 0.00%0 shares | −5.21 ppfrom 5.21%Below 5% | Mar 13, 2026 | SEC |
| Mar 6, 202612:57 PM ET | T. Rowe Price Investment Management, Inc. | 13G | 11.30%6.21M shares | New | Feb 28, 2026 | SEC |
| Feb 17, 20268:27 AM ET | RTW Investments, LPand 1 other | 13G/A | 4.90%2.71M shares | −1.10 ppfrom 6.00%Below 5% | Dec 31, 2025 | SEC |
| Feb 10, 202611:23 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 8.70%4.75M shares | −1.90 ppfrom 10.60% | Dec 31, 2025 | SEC |
| Jan 30, 20261:28 PM ET | Vanguard Group Inc | 13G | 5.21%2.86M shares | New | Dec 31, 2025 | SEC |
| Jan 22, 20268:00 PM ET | Fairmount Funds Management LLCand 3 others | 13D/A | 9.99%6.05M shares | 0.00 ppfrom 9.99% | Jan 22, 2026 | SEC |
| Nov 14, 20257:27 AM ET | Driehaus Capital Management LLC | 13G/A | 4.68%2.16M shares | –Below 5% | Sep 30, 2025 | SEC |
| Oct 14, 20257:11 PM ET | Fairmount Funds Management LLCand 3 others | 13D/A | 9.99%5.78M shares | – | Oct 10, 2025 | SEC |
| Aug 6, 202511:51 AM ET | FMR LLCand 1 other | 13G/A | 15.00%6.91M shares | – | Jun 30, 2025 | SEC |
| Aug 5, 20251:44 PM ET | Wellington Management Group LLPand 3 others | 13G/A | 10.60%4.89M shares | +2.30 ppfrom 8.30% | Jul 31, 2025 | SEC |
| Aug 5, 20251:35 PM ET | Wellington Management Group LLPand 3 others | 13G/A | 8.30%3.81M shares | −3.60 ppfrom 11.90% | Jun 30, 2025 | SEC |
| Jul 16, 20257:02 PM ET | BlackRock, Inc. | 13G/A | 5.50%2.52M shares | – | Jun 30, 2025 | SEC |
| May 12, 202510:44 AM ET | Wellington Management Group LLPand 3 others | 13G/A | 11.90%5.49M shares | – | Mar 31, 2025 | SEC |
| Feb 14, 20259:00 AM ET | RTW Investments, LPand 1 other | 13G | 6.00%2.71M shares | New | Dec 31, 2024 | SEC |
| Nov 14, 2024 | Deep Track Capital, LP | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Ra Capital Management, L.P. | 13G/AOld format | – | – | – | SEC |
| Nov 14, 2024 | Driehaus Capital Management LLC | 13GOld format | – | New | – | SEC |
| Nov 12, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Nov 8, 2024 | BlackRock, Inc. | 13GOld format | – | – | – | SEC |
| Nov 4, 2024 | Access Industries Management, LLC | 13G/AOld format | – | – | – | SEC |
| Oct 22, 2024 | BlackRock, Inc. | 13GOld format | – | New | – | SEC |
| Oct 4, 2024 | Wellington Management Group LLP | 13GOld format | – | New | – | SEC |
| Apr 1, 2024 | Fairmount Funds Management LLC | 13D/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Deep Track Capital, LP | 13G/AOld format | – | – | – | SEC |
| Feb 14, 2024 | Ra Capital Management, L.P. | 13GOld format | – | New | – | SEC |
| Feb 9, 2024 | FMR LLC | 13G/AOld format | – | – | – | SEC |
| Jan 31, 2024 | Fairmount Funds Management LLC | 13D/AOld format | – | – | – | SEC |
| Nov 3, 2023 | Access Industries Management, LLC | 13GOld format | – | New | – | SEC |
| Aug 10, 2023 | FMR LLC | 13GOld format | – | New | – | SEC |
| Jul 28, 2023 | Venrock Healthcare Capital Partners III, L.P. | 13DOld format | – | New | – | SEC |
| Jul 24, 2023 | Deep Track Capital, LP | 13GOld format | – | New | – | SEC |
| Jul 21, 2023 | Fairmount Funds Management LLC | 13DOld format | – | New | – | SEC |
Form 144: proposed insider sales
34 notices from officers, directors and other affiliates planning to sell Apogee Therapeutics, Inc. shares, newest first.
| Filed (ET) | Seller | Shares to sell | Market value | Planned sale | Broker | Filing |
|---|---|---|---|---|---|---|
| Jul 1, 20265:00 PM ET | Carl DambkowskiOfficer | 16.5K | $2.19M | Jul 1, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 22, 20264:48 PM ET | Carl DambkowskiOfficer | 15.4K | $1.39M | Jun 22, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jun 22, 202610:40 AM ET | Henderson Michael ThomasOfficer · Director | 80.0K | $10.6M | Jun 22, 202610b5-1 | THE CHARLES SCHWAB CORPORATION | SEC |
| May 13, 202610:34 AM ET | Henderson Michael ThomasOfficer · Director | 60.0K | $4.95M | May 13, 202610b5-1 | THE CHARLES SCHWAB CORPORATION | SEC |
| May 6, 20264:25 PM ET | Carl DambkowskiOfficer | 22.0K | $1.83M | May 6, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| May 1, 20264:45 PM ET | Jane HendersonOfficer | 2.00K | $165.8K | May 1, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Mar 25, 20264:24 PM ET | Jane HendersonOfficer | 6.00K | $438.0K | Mar 25, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Feb 11, 202610:42 AM ET | Henderson Michael ThomasOfficer · Director | 60.0K | $3.84M | Feb 11, 202610b5-1 | THE CHARLES SCHWAB CORPORATION | SEC |
| Jan 22, 20268:03 PM ET | Fairmount Healthcare Fund II L.P.Director | 1.75M | $133.5M | Jan 22, 2026 | Jefferies LLC | SEC |
| Jan 7, 20264:27 PM ET | Carl DambkowskiOfficer | 35.2K | $2.75M | Jan 7, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jan 2, 20264:31 PM ET | Jane HendersonOfficer | 12.0K | $905.8K | Jan 2, 202610b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 19, 20254:24 PM ET | Jane HendersonOfficer | 1.50K | $116.0K | Dec 19, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 4, 20254:43 PM ET | Jane HendersonOfficer | 1.50K | $111.8K | Dec 4, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Dec 4, 20254:41 PM ET | Carl DambkowskiOfficer | 10.9K | $812.6K | Dec 4, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 25, 20254:28 PM ET | Jane HendersonOfficer | 1.50K | $101.8K | Nov 25, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 14, 20254:31 PM ET | Jane HendersonOfficer | 2.00K | $125.9K | Nov 14, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 13, 202510:33 AM ET | Henderson Michael ThomasOfficer · Director | 100.0K | $6.70M | Nov 13, 202510b5-1 | THE CHARLES SCHWAB CORPORATION | SEC |
| Nov 12, 20257:03 AM ET | Jane HendersonOfficer | 1.00K | $56.8K | Nov 11, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Nov 5, 20254:17 PM ET | Carl DambkowskiOfficer | 10.8K | $581.3K | Nov 5, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Jul 2, 20254:22 PM ET | Carl DambkowskiOfficer | 22.3K | $989.0K | Jul 2, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Apr 2, 20254:23 PM ET | Carl DambkowskiOfficer | 9.31K | $331.5K | Apr 2, 202510b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
| Mar 5, 20251:46 PM ET | Henderson Michael ThomasOfficer · Director | 10.0K | $301.5K | Mar 5, 202510b5-1 | RBC CAPITAL MARKETS LLC | SEC |
| Feb 5, 20252:02 PM ET | Henderson Michael ThomasDirector · CEO | 15.0K | $608.7K | Feb 5, 202510b5-1 | RBC CAPITAL MARKETS LLC | SEC |
| Jan 8, 202512:23 PM ET | Henderson Michael ThomasOfficer · Director | 15.0K | $732.7K | Jan 8, 202510b5-1 | RBC CAPITAL MARKETS LLC | SEC |
| Dec 11, 20244:59 PM ET | Carl DambkowskiOfficer | 18.2K | $878.6K | Dec 11, 202410b5-1 | Morgan Stanley Smith Barney LLC Executive Financial Services | SEC |
Showing the latest 25. See the APGE notices from the last 12 months